Literature DB >> 15842047

Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.

Zhong Jiang1, Cuizhen Li, Andrew Fischer, Karen Dresser, Bruce A Woda.   

Abstract

We assessed the usefulness of immunohistochemical analysis with a 3-antibody cocktail (alpha-methylacyl coenzyme A racemase [AMACR, or P504S], 34betaE12, p63) and a double-chromogen reaction for detection of limited prostate cancer in 138 needle biopsy specimens, including 82 with small foci of prostatic adenocarcinoma and 56 benign prostates. When carcinoma was present, red cytoplasmic granular staining (AMACR) in the malignant glands and cells and dark brown nuclear (p63) and cytoplasmic (34betaE12) staining in basal cells of adjacent nonmalignant glands were found. Of 82 cases of small foci of prostatic adenocarcinoma, 78 (95%) expressed AMACR; all malignant glands were negative for basal cell staining. All benign glands adjacent to malignant glands were recognized easily by basal cell marker positivity and little or no AMACR expression. No benign glands were simultaneously positive for AMACR and negative for basal cell markers (specificity, 100%). There were no differences in intensity and numbers of positive glands with double-chromogen staining compared with using 1-color staining. Our results indicate that immunohistochemistry with a 3-antibody cocktail and double chromogen is a simple and easy assay that can be used as a routine test, which overcomes the problems of studying small lesions in prostate needle biopsies with multiple immunohistochemical stains.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15842047     DOI: 10.1309/1g1nk9dbgfnb792l

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  26 in total

1.  Quantitative immunohistochemical detection of the molecular expression patterns in proliferative inflammatory atrophy.

Authors:  M Karaivanov; K Todorova; A Kuzmanov; S Hayrabedyan
Journal:  J Mol Histol       Date:  2006-12-15       Impact factor: 2.611

2.  Evaluation of routine application of P504S, 34betaE12 and p63 immunostaining on 250 prostate needle biopsy specimens.

Authors:  Kitty Pavlakis; Konstantinos Stravodimos; Theodoros Kapetanakis; Alkiviadis Gregorakis; Sofia Athanassiadou; Olympia Tzaida; Constantinos Constantinides
Journal:  Int Urol Nephrol       Date:  2009-08-05       Impact factor: 2.370

3.  Ductal and Acinar Adenocarcinoma of Prostate: Morphological and Immunohistochemical Characterization.

Authors:  Faraz A Baig; Amna Hamid; Talat Mirza; Serajuddaula Syed
Journal:  Oman Med J       Date:  2015-05

4.  Near-infrared fluorescent digital pathology for the automation of disease diagnosis and biomarker assessment.

Authors:  Summer L Gibbs; Elizabeth Genega; Jeffery Salemi; Vida Kianzad; Haley L Goodwill; Yang Xie; Rafiou Oketokoun; Parmeshwar Khurd; Ali Kamen; John V Frangioni
Journal:  Mol Imaging       Date:  2015       Impact factor: 4.488

Review 5.  Diagnosis of adenocarcinoma in prostate needle biopsy tissue.

Authors:  P A Humphrey
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

6.  A new Ki-67 / E-cadherin cocktail reduces inter-observer variation of the calculated proliferative index.

Authors:  Golan Bubis; Ohad Hilly; Roy Bubis; Marisa Halpern; Ariel Schwartz; Rumelia Koren; Lea Rath-Wolfson
Journal:  Pathol Oncol Res       Date:  2013-07-07       Impact factor: 3.201

Review 7.  Newer developments in immunohistology.

Authors:  A S-Y Leong; T Y-M Leong
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

Review 8.  Urinary biomarkers for prostate cancer: a review.

Authors:  Daphne Hessels; Jack A Schalken
Journal:  Asian J Androl       Date:  2013-03-25       Impact factor: 3.285

9.  Pathologic results of radical prostatectomies in patients with simultaneous atypical small acinar proliferation and prostate cancer.

Authors:  Kwang Ho Kim; Yun Beom Kim; Jeong Kee Lee; Yoon Jung Kim; Tae Young Jung
Journal:  Korean J Urol       Date:  2010-06-21

10.  ERG expression and prostatic adenocarcinoma.

Authors:  Montse Verdu; Isabel Trias; Ruth Roman; Natalia Rodon; Beatriz Garcia-Pelaez; Miquel Calvo; Arturo Dominguez; Josep M Banus; Xavier Puig
Journal:  Virchows Arch       Date:  2013-05-24       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.